Alacrita Consultant, Saadia Basharat PhD, will attend the 18th Annual Superbugs and Superdrugs -Pushing Financial Incentives and Collaborative Incentives to Accelerate Clinical Success in London, UK on March 16-17.
Saadia is a consultant with experience in technology assessment of a wide range of life science products, market opportunity assessment, top level business-plan development and IP landscape analysis.
The conference will address the threat of antibiotic resistant microbes and will discuss investment, R&D, and current strategies in the fight against drug resistance. Topics will include new insights of pathogen-host interactions, monoclonal antibody based approaches to fight severe bacterial infections, and new business models for antibiotics.